EQRX Fundamental Analysis - EQRX INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to EQRX. EQRX was compared to 551 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for EQRX as it has an excellent financial health rating, but there are worries on the profitability. EQRX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EQRX has reported negative net income.

In the past year EQRX has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of EQRX (-20.04%) is better than 81.92% of its industry peers.

Looking at the Return On Equity, with a value of -21.05%, EQRX belongs to the top of the industry, outperforming 85.07% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-20.04%
ROE	-21.05%
ROIC	N/A

ROA(3y)-22.45%

ROA(5y)N/A

ROE(3y)-23.54%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EQRX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for EQRX has been increased compared to 1 year ago.

EQRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

EQRX has an Altman-Z score of 11.47. This indicates that EQRX is financially healthy and has little risk of bankruptcy at the moment.

EQRX has a Altman-Z score of 11.47. This is amongst the best in the industry. EQRX outperforms 91.54% of its industry peers.

There is no outstanding debt for EQRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	11.47

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

EQRX has a Current Ratio of 22.60. This indicates that EQRX is financially healthy and has no problem in meeting its short term obligations.

EQRX has a Current ratio of 22.60. This is amongst the best in the industry. EQRX outperforms 96.02% of its industry peers.

A Quick Ratio of 22.60 indicates that EQRX has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 22.60, EQRX belongs to the best of the industry, outperforming 96.02% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	22.6
Quick Ratio	22.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EQRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.64%.

EPS 1Y (TTM)-62.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%11.76%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, EQRX will show a decrease in Earnings Per Share. The EPS will decrease by -9.08% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-92.67%

EPS Next 2Y-37.78%

EPS Next 3Y-19.35%

EPS Next 5Y-9.08%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

EQRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year EQRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as EQRX's earnings are expected to decrease with -19.35% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-37.78%

EPS Next 3Y-19.35%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EQRX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EQRX INC

NASDAQ:EQRX (11/8/2023, 8:00:02 PM)

After market: 2.39 +0.05 (+2.14%)

2.34

-0.05 (-2.09%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)11-09 2023-11-09/amc

Earnings (Next)N/A N/A

Inst Owners3.06%

Inst Owner Change0%

Ins Owners0.52%

Ins Owner Change0%

Market Cap1.26B

Analysts42.86

Price Target2.14 (-8.55%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-12.13%

Min EPS beat(2)-15.79%

Max EPS beat(2)-8.46%

EPS beat(4)2

Avg EPS beat(4)16.22%

Min EPS beat(4)-15.79%

Max EPS beat(4)75.91%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-17.65%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-15.11%

EPS NY rev (1m)0%

EPS NY rev (3m)-15.71%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	1.01
P/tB	1.01
EV/EBITDA	N/A

EPS(TTM)-0.55

EYN/A

EPS(NY)-0.68

Fwd EYN/A

FCF(TTM)-0.62

FCFYN/A

OCF(TTM)-0.61

OCFYN/A

SpS0

BVpS2.32

TBVpS2.32

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-20.04%
ROE	-21.05%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-22.45%

ROA(5y)N/A

ROE(3y)-23.54%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	203.78%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	22.6
Quick Ratio	22.6
Altman-Z	11.47

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)346.9%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-62.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%11.76%

EPS Next Y-92.67%

EPS Next 2Y-37.78%

EPS Next 3Y-19.35%

EPS Next 5Y-9.08%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y1.88%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-11.34%

EBIT Next 3Y2.85%

EBIT Next 5Y0.08%

FCF growth 1Y-57.06%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-56.82%

OCF growth 3YN/A

OCF growth 5YN/A

EQRX INC (EQRX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens